In addition to CTLA-4-CD28 fusion genes and CD28 gain/amplification [2, 28], a recent study shows that CD28 mutations were present in PTCL-TBX21 subtype (5.3%) and AITL (11.3%) [13]. Here, CD28 is linked to mature T-cell and NK-cell non-Hodgkin lymphoma.